Commission Implementing Regulation (EU) 2023/515 of 8 March 2023 renewing the approval of the active substance abamectin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)
Articolo 1Renewal of the approval of the active substance
In vigore · versione del 12 mar 2023
The approval of the active substance abamectin, as specified in Annex I, is renewed subject to the conditions laid down in that Annex.